Screener
XLV vs XPH
State Street Health Care Select Sector SPDR ETF vs State Street SPDR S&P Pharmaceuticals ETF
Key differences
- XLV costs 0.27% less per year.
- XLV is significantly larger than XPH — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, XPH has delivered higher annualized returns.
- XLV has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| XLV | XPH | |
|---|---|---|
| Annual cost (TER) | 0.08% | 0.35% |
| Fund size (AUM) | $37.9B | $355M |
| Since | 1998 | 2006 |
| Dividend yield | 1.72% | 0.65% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +15.9% | +46.3% |
| CAGR 3Y | +6.3% | +13.8% |
| CAGR 5Y | +5.7% | +4.5% |
| Sharpe 3Y | 0.26 | 0.57 |
| Volatility 1Y | 14.55% | 21.29% |
| Max drawdown | -28.40% | -35.96% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XLV and XPH
Explore further